{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T13:28:11Z","timestamp":1781011691160,"version":"3.54.1"},"reference-count":18,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LGF21H190004"],"award-info":[{"award-number":["LGF21H190004"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hepatobiliary & Pancreatic Diseases International"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.hbpd.2021.09.005","type":"journal-article","created":{"date-parts":[[2021,9,8]],"date-time":"2021-09-08T18:29:25Z","timestamp":1631125765000},"page":"598-600","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Glucagonoma syndrome with necrolytic migratory erythema as initial manifestation"],"prefix":"10.1016","volume":"20","author":[{"given":"Wei-Fang","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Sen","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hbpd.2021.09.005_bib0001","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1001\/jamadermatol.2019.1658","article-title":"Necrolytic migratory erythema","volume":"155","author":"Liu","year":"2019","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.hbpd.2021.09.005_bib0002","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1046\/j.1365-4362.1997.00042.x","article-title":"Glucagonoma and pseudoglucagonoma syndromes","volume":"36","author":"Schwartz","year":"1997","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.hbpd.2021.09.005_bib0003","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0002-9343(87)90424-4","article-title":"Glucagonoma syndrome","volume":"82","author":"Bloom","year":"1987","journal-title":"Am J Med"},{"key":"10.1016\/j.hbpd.2021.09.005_bib0004","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0738-081X(93)90103-J","article-title":"The glucagonoma syndrome","volume":"11","author":"Wynick","year":"1993","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.hbpd.2021.09.005_bib0005","first-page":"120","article-title":"Necrolytic migratory erythema: unresolved problems in diagnosis and pathogenesis. A case report and literature review","volume":"49","author":"Kasper","year":"1992","journal-title":"Cutis"},{"key":"10.1016\/j.hbpd.2021.09.005_bib0006","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2018-229115","article-title":"Resolution of necrolytic migratory erythema with somatostatin analogue in a patient diagnosed with pancreatic glucagonoma","volume":"12","author":"Saavedra","year":"2019","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.hbpd.2021.09.005_bib0007","first-page":"4","article-title":"Etiology and pathogenesis of necrolytic migratory erythema: review of the literature","volume":"6","author":"Tierney","year":"2004","journal-title":"MedGenMed"},{"key":"10.1016\/j.hbpd.2021.09.005_bib0008","first-page":"473","article-title":"Clinical experience in diagnosis and treatment of glucagonoma syndrome","volume":"3","author":"Zhang","year":"2004","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"10.1016\/j.hbpd.2021.09.005_bib0009","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1056\/NEJMicm1915564","article-title":"Necrolytic migratory erythema associated with a glucagonoma","volume":"383","author":"Banerjee","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hbpd.2021.09.005_bib0010","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.abd.2020.02.011","article-title":"Necrolytic migratory erythema associated with painful plantar keratoderma. A new diagnostic clue for this paraneoplastic syndrome?","volume":"95","author":"Gracia-Darder","year":"2020","journal-title":"An Bras Dermatol"},{"key":"10.1016\/j.hbpd.2021.09.005_bib0011","doi-asserted-by":"crossref","first-page":"E286","DOI":"10.1503\/cmaj.180913","article-title":"Necrolytic migratory erythema","volume":"191","author":"Lee","year":"2019","journal-title":"CMAJ"},{"key":"10.1016\/j.hbpd.2021.09.005_bib0012","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1136\/postgradmedj-2020-137587","article-title":"Necrolytic migratory erythema: an important sign of glucagonoma","volume":"97","author":"Cui","year":"2021","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.hbpd.2021.09.005_bib0013","first-page":"181","article-title":"Endocrine tumors of the pancreas and their clinical syndromes","volume":"18","author":"Kaplan","year":"1986","journal-title":"Surg Annu"},{"key":"10.1016\/j.hbpd.2021.09.005_bib0014","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1530\/eje.0.1510531","article-title":"The glucagonoma syndrome and necrolytic migratory erythema: a clinical review","volume":"151","author":"van Beek","year":"2004","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.hbpd.2021.09.005_bib0015","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1186\/1752-1947-5-402","article-title":"Glucagonoma syndrome: a case report","volume":"5","author":"Castro","year":"2011","journal-title":"J Med Case Rep"},{"key":"10.1016\/j.hbpd.2021.09.005_bib0016","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1111\/jdv.13752","article-title":"Glucagonoma syndrome: a review and update on treatment","volume":"30","author":"John","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.hbpd.2021.09.005_bib0017","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1056\/NEJMoa1003825","article-title":"Sunitinib malate for the treatment of pancreatic neuroendocrine tumors","volume":"364","author":"Raymond","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hbpd.2021.09.005_bib0018","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1517\/17425255.2010.506872","article-title":"Benefits from pharmacological and pharmacokinetic properties of sunitinib for clinical development","volume":"6","author":"Sablin","year":"2010","journal-title":"Expert Opin Drug Metab Toxicol"}],"container-title":["Hepatobiliary & Pancreatic Diseases International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1499387221001752?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1499387221001752?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T15:42:07Z","timestamp":1761493327000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1499387221001752"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":18,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S1499387221001752"],"URL":"https:\/\/doi.org\/10.1016\/j.hbpd.2021.09.005","relation":{},"ISSN":["1499-3872"],"issn-type":[{"value":"1499-3872","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glucagonoma syndrome with necrolytic migratory erythema as initial manifestation","name":"articletitle","label":"Article Title"},{"value":"Hepatobiliary & Pancreatic Diseases International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hbpd.2021.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 First Affiliated Hospital, Zhejiang University School of Medicine in China. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}